HealthEquity, Inc. (HQY) News

HealthEquity, Inc. (HQY): $84.75

0.87 (+1.04%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add HQY to Watchlist
Sign Up

Filter HQY News Items

HQY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HQY News Highlights

  • HQY's 30 day story count now stands at 20.
  • Over the past 22 days, HQY's stories per day has been in a clear uptrend, growing by about 0.13 per day.
  • The most mentioned tickers in articles about HQY are HAE, ITGR and QDEL.

Latest HQY News From Around the Web

Below are the latest news stories about HEALTHEQUITY INC that investors may wish to consider to help them evaluate HQY as an investment opportunity.

3 Reasons to Hold Zimmer Biomet (ZBH) Stock in Your Portfolio

Zimmer Biomet's (ZBH) focus on emerging markets raises optimism about the stock.

Yahoo | December 28, 2023

Does HealthEquity (HQY) Have the Potential to Rally 31.37% as Wall Street Analysts Expect?

The consensus price target hints at a 31.4% upside potential for HealthEquity (HQY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | December 28, 2023

3 Amazing Health Service Stocks to Brave "Labordemic" in 2024

Here are the three stocks, MEDP, ELV and HQY, which have the potential to shield your portfolio from the impact of healthcare staffing challenges in 2024.

Yahoo | December 28, 2023

5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024

Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024.

Yahoo | December 26, 2023

McKesson (MCK) Announces Availability of PNH's FDA-Approved Drug

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH.

Yahoo | December 26, 2023

Former Director Ian Sacks Sells 45,000 Shares of HealthEquity Inc (HQY)

Ian Sacks, a former director of HealthEquity Inc (NASDAQ:HQY), has sold 45,000 shares of the company on December 19, 2023, according to a recent SEC Filing.

Yahoo | December 22, 2023

Here's Why You Should Retain Veeva Systems (VEEV) Stock Now

Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.

Yahoo | December 22, 2023

HealthEquity (HQY) Performed Strongly in Q3

Wasatch Global Investors, an investment management firm, released its “Wasatch Small Cap Growth Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. Stocks fell broadly in the quarter as investors worried about the consequences of rising interest rates and a possible recession. During the quarter, the strategy declined but […]

Yahoo | December 22, 2023

QuidelOrtho's (QDEL) Latest FDA Nod to Boost Diagnostic Testing

QuidelOrtho's (QDEL) receipt of the FDA's latest approval is likely to improve clinical care, provide cost savings and deliver sample-to-result molecular testing across all laboratory settings.

Yahoo | December 21, 2023

Veeva Systems (VEEV) Vault Quality Offerings Adopted by Recipharm

Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid Recipharm in boosting its operational efficiencies.

Yahoo | December 20, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!